BioNTech (BNTX) PT Lowered to $191 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $91.91 -1.27%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Join SI Premium – FREE
Canaccord Genuity analyst William Maughan lowered the price target on BioNTech (NASDAQ: BNTX) to $191.00 (from $200.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
Create E-mail Alert Related Categories
Analyst PT Change, Hot CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
